Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 8.8B | 8.4B | 8.7B |
Cost of revenue | 5.5B | 5.6B | 5.4B | 5.5B |
Gross profit | 3.4B | 3.1B | 3.1B | 3.2B |
Operating expense | ||||
Research & development | 192M | 186M | 171M | 180M |
Selling general and admin | 1.6B | 1.5B | 1.4B | 1.5B |
Other operating expenses | 292M | 219M | 254M | 194M |
Operating income | 1.5B | 1.4B | 1.3B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.3B | 1.1B | 1.3B |
Tax provision | 316M | 326M | 283M | 321M |
Net income | 941M | 932M | 836M | 988M |
Basic EPS | 4.1 | 4.0 | 3.5 | 4.1 |
Diluted EPS | 4.1 | 4.0 | 3.5 | 4.1 |
Basic average shares | 230.8M | 233.6M | 236.6M | 238.7M |
Diluted average shares | 230.8M | 233.6M | 236.6M | 238.7M |
EBITDA | 2.0B | 2.0B | 1.9B | 2.1B |
Net income from continuing op. | 1.4B | 1.3B | 1.2B | 1.4B |
Minority interests | 0 | 1M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |